SCHEMBL719201

SCHEMBL719201

CCCCCCCCCCCCCCCCN(CC(O)CN)CC(O)C(O)CN(CCCCCCCCCCCCCCCC)CC(O)CN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
PLA2G1B P04054 1/20 0.42
PLA2G2A P14555 1/20 0.42
KCNH2 Q12809 4/20 0.37
SPHK1 Q9NYA1 2/20 0.36
CACNA1F O60840 1/20 0.35
CHRM2 P08172 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35
DRD3 P35462 1/20 0.35
CACNA1D Q01668 1/20 0.35
CACNA1S Q13698 1/20 0.35
CACNA1C Q13936 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DNM1 Q05193 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718257 1.00 HTT (0.43) HTTPLA2G1BPLA2G2AKCNH2SPHK1
SCHEMBL718599 0.91 MEN1 (0.39) HTTSPHK1KDM4EMAPK1CYP2D6
SCHEMBL16813073 0.91 HTT (0.47) HTTPLA2G1BPLA2G2AKCNH2KDM4E
SCHEMBL19467362 0.85 HTT (0.36) HTTPLA2G1BPLA2G2A
SCHEMBL721174 0.85 MEN1 (0.42) HTTSPHK1KDM4EMAPK1CYP2D6
SCHEMBL721173 0.85 MEN1 (0.42) HTTSPHK1KDM4EMAPK1CYP2D6
SCHEMBL22026425 0.84 GGPS1 (0.44) HTTPLA2G1BPLA2G2ACHRM2KDM4E
SCHEMBL14619487 0.83 PLA2G1B (0.35) HTTPLA2G1BPLA2G2AKCNH2CACNA1F
SCHEMBL7356304 0.83 KDM4E (0.46) HTTPLA2G1BPLA2G2AKDM4EMAPK1
SCHEMBL22354437 0.82 PLA2G1B (0.47) PLA2G1BPLA2G2AKCNH2SPHK1CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565572-A1 LIPIDS FOR NUCLEIC ACID DELIVERY Life Technologies Corporation (US) 2025-06-11 EP claimed
WO-2025034802-A2 AGENTS FOR DELIVERY OF NUCLEIC ACIDS Life Technologies Corporation (US) 2025-02-13 WO claimed
WO-2025034764-A1 LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS Life Technologies Corporation (US) 2025-02-13 WO claimed
CN-119137109-A Lipids for nucleic acid delivery 生命技术公司 2024-12-13 CN claimed
WO-2024031051-A1 LIPIDS FOR NUCLEIC ACID DELIVERY Life Technologies Corporation (US) 2024-02-08 WO claimed
EP-4175967-A2 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation (US) 2023-05-10 EP claimed
WO-2022006368-A2 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation (US) 2022-01-06 WO claimed
US-10155780-B2 Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells MOLECULAR TRANSFER, INC. (US) 2018-12-18 US claimed
US-20170029448-A1 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2017-02-02 US claimed
EP-2912045-A2 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2015-09-02 EP claimed
WO-2014070687-A2 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2014-05-08 WO claimed
EP-2015780-B1 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER INC (US) 2012-12-12 EP claimed
US-7915230-B2 Reagents for transfection of eukaryotic cells MOLECULAR TRANSFER, INC. (US) 2011-03-29 US claimed
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells MOLECULAR TRANSFER (US) 2009-01-22 US claimed
EP-4710943-A2 TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME Molecular Transfer, Inc. (US) 2026-03-18 EP disclosed
EP-4642434-A2 LIPID COMPOSITIONS ON THE BASIS OF IONIZABLE LIPIDS, USE FOR DELIVERY TO IMMUNE CELLS Life Technologies Corporation (US) 2025-11-05 EP disclosed
US-20250333729-A1 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation 2025-10-30 US disclosed
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells MOLECULAR TRANSFER (US) 2009-01-22 US disclosed
EP-2015780-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2009-01-21 EP disclosed
WO-2007130073-A2 NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10155780-B2 Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells PHOSPHO1, MBOAT7, PLTP HTT 1930/4885PLA2G1B 114/4885PLA2G2A 40/4885
US-20170029448-A1 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS PHOSPHO1, PLTP, MBOAT7 HTT 2665/4885PLA2G1B 64/4885PLA2G2A 48/4885
US-20090023215-A1 Novel reagents for transfection of eukaryotic cells FUS, PHAX, PICALM HTT 1075/4885PLA2G1B 1523/4885PLA2G2A 562/4885
US-20250333729-A1 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF RNGTT, RNMT, CPSF7 HTT 773/4885PLA2G1B 2983/4885PLA2G2A 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.